NOTE: This order is nonprecedential United States Court of AppeaIs for the FederaI Circuit IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs-Appellees, V. AUROBINDO PHARMA LIMITED, Defen,dcmt-Appellant, AND MYLAN PHARMACEUTICALS INC., Defendant-Appellan,t, AND APOTEX CORP., Defendant-Appellant, AND COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC., Defendan,ts-Appellan,ts, AND SUN PHARMACEUTICAL INDUSTRIES, LTD., Defen,dant-Appellant, ASTRAZEN`ECA PHA.RMA V. AUROBINDO 2 AND TEVA PHARMACEUTICALS USA, INC., Defendan,t-Appellant, AND PAR PHARMACEUTICAL, INC., Defendant-Appellan,t, AND SANDOZ, INC., Defen,dant.

2010-1460, -1461, -1462, -1463, -i464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 Appeals from the United States District Court for the District of De1aWare in case nos. 08-MD-1949, O'7-CV- O81O, 07-CV-0805, 07-CV-0809, 07-CV-0811, 07~CV-0806, O8~CV-0426, and 07-CV-0808, Judge Joseph J. Farnan, Jr. ON MOTION ORDER Upon consideration of Apotex, Inc., AstraZeneca Phar- maceutica1S LP and Aurobind0 Pharma USA Inc.’s unop- posed motion to be removed as parties in the caption, IT IS ORDERED THAT2 The motions are granted The revised official caption is reflected above. cc.

S ASTRAZENECA PHABMA V. AUROBINDO FoR THE C0URT 9 /s/ Jan Horba1y Date J an Horbaly Charles E. Lipsey, Esq.

R0bert B. Breisb1att, Esq.

Jeffrey S. Ward, Esq.

Steven A. Maddox, Esq.

Wil1iam A. Rakoczy, Esq.

Dutch Chung, Esq.

J ames F. Hurst, Esq.

Richard A. Kap1an, Esq.

C1erk Fl u.s. c0uR‘r 0llFE\PPzALs ron Tl-us FEoERAL clncurr SEP 0 9 -2019 JAN HORBALY CLERK